MedTrace Logo

Impact of Prenatal Vitamin/Mineral Supplements on Perinatal Mortality

NCT00133744 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 18962

Last updated 2011-03-21

No results posted yet for this study

Summary

The purpose of this study is to determine whether a daily prenatal supplement of iron plus folic acid or a daily prenatal supplement with multiple vitamins and minerals given to women from their first prenatal visit through delivery reduces perinatal mortality compared with a daily prenatal supplement of folic acid alone.

Conditions

  • Perinatal Mortality
  • Stillbirth
  • Neonatal Mortality

Interventions

DIETARY_SUPPLEMENT

folic acid

pills by mouth, one per day, from the first prenatal visit until delivery, 400 micrograms (mcg) folic acid

DIETARY_SUPPLEMENT

folic acid plus iron

pills by mouth, one per day, from the first prenatal visit until delivery, 400 mcg folic acid, 30 mg Fe

DIETARY_SUPPLEMENT

supplements with multiple vitamins and minerals

pills, one per day, from the first prenatal visit until delivery; folic acid 400 mcg, Fe 30 mg, vitamin(vit) A 800 mcg, vit E 10 mg, vit D 5 mcg, vit C 70 mg, vit B1 1.4 mg, vit B2 1.4 mg, vit B6 1.9 mg, vit B12 2.6 mcg, Niacin 18 mg, Zn 15 mg, Cu 2mg, Iodine 150 mcg, Selenium 65 mcg

Sponsors & Collaborators

Principal Investigators

  • Weicheng You, MD, MBA · Peking University Health Science Center, Beijing China

  • Jianmeng Liu, MD, PhD · Institute of Reproductive and Child Health, Peking University Health Science Center, Beijing China

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-05-31
Primary Completion
2009-12-31
Completion
2010-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00133744 on ClinicalTrials.gov